# reAlpha Tech Corp.: overview AIRE · Nasdaq · CIK 1859199 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/aire.md) · [Financials](/companies/aire/financials.md) · [Filings](/companies/aire/filings.md) · [Insiders](/companies/aire/insiders.md) Latest reported revenue: [$1.1m](/filings/0001213900-26-090106.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-090106). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [339](/filings/0001213900-25-108695.md) | [526 d](/filings/0001213900-26-026653.md) | [926](/filings/0001213900-26-048242.md) | [1,252](/filings/0001213900-26-090106.md) | [1,445](/filings/0001213900-25-108695.md) | [895 d](/filings/0001213900-26-026653.md) | [841](/filings/0001213900-26-048242.md) | [1,110](/filings/0001213900-26-090106.md) | | Gross margin | % | [66.6%](/filings/0001213900-25-108695.md) | [69.2% d](/filings/0001213900-26-026653.md) | [56.0%](/filings/0001213900-26-048242.md) | [49.6%](/filings/0001213900-26-090106.md) | [51.9%](/filings/0001213900-25-108695.md) | [62.7% d](/filings/0001213900-26-026653.md) | [65.7%](/filings/0001213900-26-048242.md) | [66.0%](/filings/0001213900-26-090106.md) | | Operating margin | % | [(479.1%)](/filings/0001213900-25-108695.md) | [(566.5%) d](/filings/0001213900-26-026653.md) | [(261.7%)](/filings/0001213900-26-048242.md) | [(326.5%)](/filings/0001213900-26-090106.md) | [(342.4%)](/filings/0001213900-25-108695.md) | [(513.3%) d](/filings/0001213900-26-026653.md) | [(509.0%)](/filings/0001213900-26-048242.md) | [(260.7%)](/filings/0001213900-26-090106.md) | | Net margin | % | [(618.6%)](/filings/0001213900-25-108695.md) | [(3994.4%) d](/filings/0001213900-26-026653.md) | [(307.9%)](/filings/0001213900-26-048242.md) | [(384.8%)](/filings/0001213900-26-090106.md) | [(400.1%)](/filings/0001213900-25-108695.md) | [(541.6%) d](/filings/0001213900-26-026653.md) | [(515.8%)](/filings/0001213900-26-048242.md) | [(274.6%)](/filings/0001213900-26-090106.md) | | Diluted EPS | $ per share | [(0.05)](/filings/0001213900-25-108695.md) | not reported | [(0.06)](/filings/0001213900-26-048242.md) | [(2.37)](/filings/0001213900-26-090106.md) | [(0.07)](/filings/0001213900-25-108695.md) | not reported | [(0.03)](/filings/0001213900-26-048242.md) | [(0.57)](/filings/0001213900-26-090106.md) | | Free cash flow | $k | [(1,263) d](/filings/0001213900-25-108695.md) | [(2,240) d](/filings/0001213900-26-026653.md) | [(2,281)](/filings/0001213900-26-048242.md) | [(2,348) d](/filings/0001213900-26-090106.md) | [(4,251) d](/filings/0001213900-25-108695.md) | [(2,426) d](/filings/0001213900-26-026653.md) | [(3,171)](/filings/0001213900-26-048242.md) | [(2,365) d](/filings/0001213900-26-090106.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-04-30) | FY (2023-04-30) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [0.3](/filings/0001213900-24-021553.md) | [0.4](/filings/0001213900-25-042783.md) | [0.9](/filings/0001213900-26-026653.md) | [4.5](/filings/0001213900-26-026653.md) | | Gross margin | % | [45.3%](/filings/0001213900-24-021553.md) | [30.1%](/filings/0001213900-25-042783.md) | [68.1%](/filings/0001213900-26-026653.md) | [54.3%](/filings/0001213900-26-026653.md) | | Operating margin | % | [(1581.3%)](/filings/0001213900-24-021553.md) | [(1176.3%)](/filings/0001213900-25-042783.md) | [(727.8%)](/filings/0001213900-26-026653.md) | [(354.3%)](/filings/0001213900-26-026653.md) | | Net margin | % | [(1761.6%)](/filings/0001213900-24-021553.md) | [(1300.2%)](/filings/0001213900-25-042783.md) | [(2743.8%)](/filings/0001213900-26-026653.md) | [(389.4%)](/filings/0001213900-26-026653.md) | | Diluted EPS | $ per share | not reported | [(0.13)](/filings/0001213900-25-042783.md) | [(0.58)](/filings/0001213900-26-026653.md) | [(0.23)](/filings/0001213900-26-026653.md) | | Free cash flow | $m | not reported | not reported | [(6.1)](/filings/0001213900-26-026653.md) | [(11.3)](/filings/0001213900-26-026653.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aire/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $104.6k | 54,191 | | New +54,191 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $83.4k | 43,201 | | New +43,201 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $81.7k | 42,289 | | New +42,289 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $78.5k | 40,658 | | New +40,658 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $58.4k | 30,239 | | New +30,239 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $44.0k | 22,786 | | New +22,786 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $42.9k | 22,210 | | New +22,210 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $14.0k | 7,236 | | New +7,236 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.0k | 1,531 | | New +1,531 | | [Pinnacle Wealth Planning Services, Inc.](/funds/1726752.md) | 2026-06-30 | $386 | 200 | | New +200 | ## Recent filings [All 371 filings](/companies/aire/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 13:29 ET | [S-1](/filings/0001213900-26-111519.md) | Registration statement | 0001213900-26-111519 | | 2026-10-21 | 10:03 ET | [8-K](/filings/0001213900-26-111152.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-111152 | | 2026-10-19 | 10:11 ET | [8-K/A](/filings/0001213900-26-110453.md) | 9.01 Financial statements and exhibits | 0001213900-26-110453 | | 2026-10-07 | 20:15 ET | [8-K](/filings/0001213900-26-107580.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-107580 | | 2026-09-25 | 20:30 ET | [DEF 14A](/filings/0001213900-26-103529.md) | Proxy statement, period 2026-11-05 | 0001213900-26-103529 | | 2026-09-23 | 12:55 ET | [8-K/A](/filings/0001213900-26-102384.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-102384 | | 2026-09-11 | 20:15 ET | [8-K](/filings/0001213900-26-099275.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-099275 | | 2026-08-25 | 20:30 ET | [8-K](/filings/0001213900-26-093535.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-093535 | | 2026-08-21 | 12:25 ET | [8-K](/filings/0001213900-26-092336.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-092336 | | 2026-08-14 | 20:37 ET | [8-K](/filings/0001213900-26-090195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090195 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-026653.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a2fcfd66-9e0f-493e-8daa-51927f026fc3) ## About the filer - CIK: 1859199 - Tickers: AIRE - Exchange: Nasdaq - SIC code: 6500 Real Estate - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.